Prostate	0	8	B-Gene_or_gene_product
-	8	9	I-Gene_or_gene_product
specific	9	17	I-Gene_or_gene_product
membrane	18	26	I-Gene_or_gene_product
antigen	27	34	I-Gene_or_gene_product
regulates	35	44	O
angiogenesis	45	57	O
by	58	60	O
modulating	61	71	O
integrin	72	80	B-Gene_or_gene_product
signal	81	87	O
transduction	88	100	O
.	100	101	O

The	103	106	O
transmembrane	107	120	O
peptidase	121	130	O
prostate	131	139	B-Gene_or_gene_product
-	139	140	I-Gene_or_gene_product
specific	140	148	I-Gene_or_gene_product
membrane	149	157	I-Gene_or_gene_product
antigen	158	165	I-Gene_or_gene_product
(	166	167	O
PSMA	167	171	B-Gene_or_gene_product
)	171	172	O
is	173	175	O
universally	176	187	O
upregulated	188	199	O
in	200	202	O
the	203	206	O
vasculature	207	218	B-Multi-tissue_structure
of	219	221	O
solid	222	227	B-Pathological_formation
tumors	228	234	I-Pathological_formation
,	234	235	O
but	236	239	O
its	240	243	O
functional	244	254	O
role	255	259	O
in	260	262	O
tumor	263	268	B-Pathological_formation
angiogenesis	269	281	O
has	282	285	O
not	286	289	O
been	290	294	O
investigated	295	307	O
.	307	308	O

Here	309	313	O
we	314	316	O
show	317	321	O
that	322	326	O
angiogenesis	327	339	O
is	340	342	O
severely	343	351	O
impaired	352	360	O
in	361	363	O
PSMA	364	368	B-Gene_or_gene_product
-	368	369	O
null	369	373	O
animals	374	381	O
and	382	385	O
that	386	390	O
this	391	395	O
angiogenic	396	406	O
defect	407	413	O
occurs	414	420	O
at	421	423	O
the	424	427	O
level	428	433	O
of	434	436	O
endothelial	437	448	B-Cell
cell	449	453	I-Cell
invasion	454	462	O
through	463	470	O
the	471	474	O
extracellular	475	488	B-Cellular_component
matrix	489	495	I-Cellular_component
barrier	496	503	I-Cellular_component
.	503	504	O

Because	505	512	O
proteolytic	513	524	O
degradation	525	536	O
of	537	539	O
the	540	543	O
extracellular	544	557	B-Cellular_component
matrix	558	564	I-Cellular_component
is	565	567	O
a	568	569	O
critical	570	578	O
component	579	588	O
of	589	591	O
endothelial	592	603	B-Cell
invasion	604	612	O
in	613	615	O
angiogenesis	616	628	O
,	628	629	O
it	630	632	O
is	633	635	O
logical	636	643	O
to	644	646	O
assume	647	653	O
that	654	658	O
PSMA	659	663	B-Gene_or_gene_product
participates	664	676	O
in	677	679	O
matrix	680	686	B-Cellular_component
degradation	687	698	O
.	698	699	O

However	700	707	O
,	707	708	O
we	709	711	O
demonstrate	712	723	O
a	724	725	O
novel	726	731	O
and	732	735	O
more	736	740	O
complex	741	748	O
role	749	753	O
for	754	757	O
PSMA	758	762	B-Gene_or_gene_product
in	763	765	O
angiogenesis	766	778	O
,	778	779	O
where	780	785	O
it	786	788	O
is	789	791	O
a	792	793	O
principal	794	803	O
component	804	813	O
of	814	816	O
a	817	818	O
regulatory	819	829	O
loop	830	834	O
that	835	839	O
is	840	842	O
tightly	843	850	O
modulating	851	861	O
laminin	862	869	B-Gene_or_gene_product
-	869	870	O
specific	870	878	O
integrin	879	887	B-Gene_or_gene_product
signaling	888	897	O
and	898	901	O
GTPase	902	908	O
-	908	909	O
dependent	909	918	O
,	918	919	O
p21	920	923	B-Gene_or_gene_product
-	923	924	I-Gene_or_gene_product
activated	924	933	I-Gene_or_gene_product
kinase	934	940	I-Gene_or_gene_product
1	941	942	I-Gene_or_gene_product
(	943	944	O
PAK	944	947	B-Gene_or_gene_product
-	947	948	I-Gene_or_gene_product
1	948	949	I-Gene_or_gene_product
)	949	950	O
activity	951	959	O
.	959	960	O

We	961	963	O
show	964	968	O
that	969	973	O
PSMA	974	978	B-Gene_or_gene_product
inhibition	979	989	O
,	989	990	O
knockdown	991	1000	O
,	1000	1001	O
or	1002	1004	O
deficiency	1005	1015	O
decreases	1016	1025	O
endothelial	1026	1037	B-Cell
cell	1038	1042	I-Cell
invasion	1043	1051	O
in	1052	1054	O
vitro	1055	1060	O
via	1061	1064	O
integrin	1065	1073	B-Gene_or_gene_product
and	1074	1077	O
PAK	1078	1081	B-Gene_or_gene_product
,	1081	1082	O
thus	1083	1087	O
abrogating	1088	1098	O
angiogenesis	1099	1111	O
.	1111	1112	O

Interestingly	1113	1126	O
,	1126	1127	O
the	1128	1131	O
neutralization	1132	1146	O
of	1147	1149	O
beta	1150	1154	B-Gene_or_gene_product
(	1154	1155	I-Gene_or_gene_product
1	1155	1156	I-Gene_or_gene_product
)	1156	1157	I-Gene_or_gene_product
or	1158	1160	O
the	1161	1164	O
inactivation	1165	1177	O
of	1178	1180	O
PAK	1181	1184	B-Gene_or_gene_product
increases	1185	1194	O
PSMA	1195	1199	B-Gene_or_gene_product
activity	1200	1208	O
,	1208	1209	O
suggesting	1210	1220	O
that	1221	1225	O
they	1226	1230	O
negatively	1231	1241	O
regulate	1242	1250	O
PSMA	1251	1255	B-Gene_or_gene_product
.	1255	1256	O

This	1257	1261	O
negative	1262	1270	O
regulation	1271	1281	O
is	1282	1284	O
mediated	1285	1293	O
by	1294	1296	O
the	1297	1300	O
cytoskeleton	1301	1313	O
as	1314	1316	O
the	1317	1320	O
disruption	1321	1331	O
of	1332	1334	O
interactions	1335	1347	O
between	1348	1355	O
the	1356	1359	O
PSMA	1360	1364	B-Gene_or_gene_product
cytoplasmic	1365	1376	O
tail	1377	1381	O
and	1382	1385	O
the	1386	1389	O
anchor	1390	1396	O
protein	1397	1404	O
filamin	1405	1412	B-Gene_or_gene_product
A	1413	1414	I-Gene_or_gene_product
decreases	1415	1424	O
PSMA	1425	1429	B-Gene_or_gene_product
activity	1430	1438	O
,	1438	1439	O
integrin	1440	1448	B-Gene_or_gene_product
function	1449	1457	O
,	1457	1458	O
and	1459	1462	O
PAK	1463	1466	B-Gene_or_gene_product
activation	1467	1477	O
.	1477	1478	O

Finally	1479	1486	O
,	1486	1487	O
the	1488	1491	O
inhibition	1492	1502	O
of	1503	1505	O
PAK	1506	1509	B-Gene_or_gene_product
activation	1510	1520	O
enhances	1521	1529	O
the	1530	1533	O
PSMA	1534	1538	B-Gene_or_gene_product
/	1538	1539	O
filamin	1539	1546	B-Gene_or_gene_product
A	1547	1548	I-Gene_or_gene_product
interaction	1549	1560	O
and	1561	1564	O
,	1564	1565	O
thus	1566	1570	O
,	1570	1571	O
boosts	1572	1578	O
PSMA	1579	1583	B-Gene_or_gene_product
activity	1584	1592	O
.	1592	1593	O

These	1594	1599	O
data	1600	1604	O
imply	1605	1610	O
that	1611	1615	O
PSMA	1616	1620	B-Gene_or_gene_product
participates	1621	1633	O
in	1634	1636	O
an	1637	1639	O
autoregulatory	1640	1654	O
loop	1655	1659	O
,	1659	1660	O
wherein	1661	1668	O
active	1669	1675	O
PSMA	1676	1680	B-Gene_or_gene_product
facilitates	1681	1692	O
integrin	1693	1701	B-Gene_or_gene_product
signaling	1702	1711	O
and	1712	1715	O
PAK	1716	1719	B-Gene_or_gene_product
activation	1720	1730	O
,	1730	1731	O
leading	1732	1739	O
to	1740	1742	O
both	1743	1747	O
productive	1748	1758	O
invasion	1759	1767	O
and	1768	1771	O
downregulation	1772	1786	O
of	1787	1789	O
integrin	1790	1798	B-Gene_or_gene_product
beta	1799	1803	I-Gene_or_gene_product
(	1803	1804	I-Gene_or_gene_product
1	1804	1805	I-Gene_or_gene_product
)	1805	1806	I-Gene_or_gene_product
signaling	1807	1816	O
via	1817	1820	O
reduced	1821	1828	O
PSMA	1829	1833	B-Gene_or_gene_product
activity	1834	1842	O
.	1842	1843	O

Therefore	1844	1853	O
,	1853	1854	O
we	1855	1857	O
have	1858	1862	O
identified	1863	1873	O
a	1874	1875	O
novel	1876	1881	O
role	1882	1886	O
for	1887	1890	O
PSMA	1891	1895	B-Gene_or_gene_product
as	1896	1898	O
a	1899	1900	O
true	1901	1905	O
molecular	1906	1915	O
interface	1916	1925	O
,	1925	1926	O
integrating	1927	1938	O
both	1939	1943	O
extracellular	1944	1957	O
and	1958	1961	O
intracellular	1962	1975	O
signals	1976	1983	O
during	1984	1990	O
angiogenesis	1991	2003	O
.	2003	2004	O

